抗悪性腫瘍薬が誘発する倦怠感発症に対するヒスタミンH3受容体作動薬の効果

抄録

We report that tumor necrosis factor-alpha (TNF-α) prodction via histamine H₄ receptors contributes to cisplatin-induced fatigue. Previous studies reported the activation of histamine H₃ receptors also have the potential to reduce the inflammatory peptides. In this study, we investigated the effects of the H₃ receptor agonist on the development of chemotherapy-induced fatigue in mice. Cisplatin (7.5 mg/kg, i.p.) induced anorexia and decrease of voluntary wheel running within 24 hours of its administration and they continued for 3 days, and daily administration of a selective H₃ receptor agonist (immethtridine, 10 mg/kg, s.c.) significantly inhibited the development of anorexia and decrease of voluntary wheel running. Cisplatin significantly increased TNF-α mRNA expression in the hypothalamus and spleen, and the period of expression increase paralleled the onset period of anorexia and decrease of voluntary wheel running. Pretreatment with immethridine inhibited splenic TNF-α mRNA expression. These results suggest that peripheral TNF-α mRNA expression via H₃ receptors may contribute to the development of cisplatin-induced fatigue.